Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the efficacy and safety of recombinant human growth hormone (r-hGH) treatment in girls with Turner Syndrome under the age of 4 years. After 4 years of treatm...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck KGaA, Darmstadt, Germany
NCT00001343 · Dwarfism, Turner's Syndrome
NCT00870220 · Turner's Syndrome
NCT00004275 · Turner's Syndrome
NCT00013546 · Osteoporosis, Turner's Syndrome
NCT00001253 · Gonadal Dysgenesis, Turner's Syndrome
Hôpital Robert Debré
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions